Literature DB >> 15503234

Quantification of isomeric equilibria formed by metal ion complexes of 8-[2-(phosphonomethoxy)ethyl]-8-azaadenine (8,8aPMEA) and 9-[2-(phosphonomethoxy)ethyl]-8-azaadenine (9,8aPMEA). Derivatives of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).

Raquel B Gómez-Coca1, Larisa E Kapinos, Antonín Holý, Rosario A Vilaplana, Francisco González-Vílchez, Helmut Sigel.   

Abstract

The acidity constants of the two-fold protonated acyclic 9-[2-(phosphonomethoxy)ethyl]-8-azaadenine, H2(9,8aPMEA)(+)(-), and its 8-isomer, 8-[2-(phosphonomethoxy)ethyl]-8-azaadenine, H2(8,8aPMEA)(+)(-), both abbreviated as H2(PA)(+)(-), as well as the stability constants of their M(H;PA)+ and M(PA) complexes with the metal ions M2+=Mg2+, Ca2+, Sr2+, Ba2+, Mn2+, Co2+, Ni2+, Cu2+, Zn2+ or Cd2+, have been determined by potentiometric pH titrations in aqueous solution at I=0.1 M (NaNO3) and 25 degrees C. Application of previously determined straight-line plots of log K(M)M(R-PO3) versus pK(H)H(R-PO3)for simple phosph(on)ate ligands, R-PO3(2-), where R represents a residue without an affinity for metal ions, proves that for all M(PA) complexes a larger stability is observed than is expected for a sole phosphonate coordination of the metal ion. This increased stability is attributed to the formation of five-membered chelates involving the ether oxygen present in the aliphatic residue (-CH2-O-CH2-PO3(2-)) of the ligands. The formation degrees of these chelates were calculated; they vary between about 13% for Ca(8,8aPMEA) and 71% for Cu(8,8aPMEA). The adenine residue has no influence on complex stability except in the Cu(9,8aPMEA) and Zn(9,8aPMEA) systems, where an additional stability increase attributable to the adenine residue is observed and equilibria between four different isomers exist. This means (1) an open isomer with a sole phosphonate coordination, M(PA)op, where PA(2-)=9,8aPMEA2-, (2) an isomer with a five-membered chelate involving the ether oxygen, M(PA)cl/O, (3) an isomer which contains five- and seven-membered chelates formed by coordination of the phosphonate group, the ether oxygen and the N3 site of the adenine residue, M(PA)cl/O/N3, and finally (4) a macrochelated isomer involving N7, M(PA)cl/N7. For Cu(9,8aPMEA) the formation degrees are 15, 30, 48 and 7% for Cu(PA)op, Cu(PA)cl/O, Cu(PA)cl/O/N3 and Cu(PA)cl/N7, respectively; this proves that the macrochelate involving N7 is a minority species. The situation for the Cu(PMEA) system, where PMEA2- represents the parent compound, i.e. the dianion of 9-[2-(phosphonomethoxy)ethyl]adenine, is quite similar. The relationship between the antiviral activity of acyclic nucleoside phosphonates and the structures of the various complexes is discussed and an explanation is offered why 9,8aPMEA is biologically active but 8,8aPMEA is not.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15503234     DOI: 10.1007/s00775-004-0591-7

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  25 in total

1.  Certain benzimidazoles, benzenes, and ribofuranosylpurines as inhibitors of influenza B virus multiplication.

Authors:  I TAMM; K FOLKERS; C H SHUNK
Journal:  J Bacteriol       Date:  1956-07       Impact factor: 3.490

Review 2.  Structural and functional insights provided by crystal structures of DNA polymerases and their substrate complexes.

Authors:  C A Brautigam; T A Steitz
Journal:  Curr Opin Struct Biol       Date:  1998-02       Impact factor: 6.809

3.  8-Azaadenosine. Crystal structure of its monohydrate and conformational analysis for rotation around the glycosyl bond.

Authors:  P Singh; D J Hodgson
Journal:  J Am Chem Soc       Date:  1977-07-06       Impact factor: 15.419

4.  Self-association and protonation of adenosine 5'-monophosphate in comparison with its 2'- and 3'-analogues and tubercidin 5'-monophosphate (7-deaza-AMP).

Authors:  R Tribolet; H Sigel
Journal:  Eur J Biochem       Date:  1987-03-02

5.  A novel selective broad-spectrum anti-DNA virus agent.

Authors:  E De Clercq; A Holý; I Rosenberg; T Sakuma; J Balzarini; P C Maudgal
Journal:  Nature       Date:  1986 Oct 2-8       Impact factor: 49.962

6.  Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro.

Authors:  A Holý; I Votruba; A Merta; J Cerný; J Veselý; J Vlach; K Sedivá; I Rosenberg; M Otmar; H Hrebabecký
Journal:  Antiviral Res       Date:  1990-06       Impact factor: 5.970

7.  Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues.

Authors:  A Merta; I Votruba; I Rosenberg; M Otmar; H Hrebabecký; R Bernaerts; A Holý
Journal:  Antiviral Res       Date:  1990-05       Impact factor: 5.970

8.  Structure-antiviral activity relationship in the series of pyrimidine and purine N-[2-(2-phosphonomethoxy)ethyl] nucleotide analogues. 1. Derivatives substituted at the carbon atoms of the base.

Authors:  A Holý; J Günter; H Dvoráková; M Masojídková; G Andrei; R Snoeck; J Balzarini; E De Clercq
Journal:  J Med Chem       Date:  1999-06-17       Impact factor: 7.446

9.  Acyclic nucleotide analogs derived from 8-azapurines: synthesis and antiviral activity.

Authors:  A Holý; H Dvoráková; J Jindrich; M Masojídková; M Budĕsínský; J Balzarini; G Andrei; E De Clercq
Journal:  J Med Chem       Date:  1996-09-27       Impact factor: 7.446

10.  Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells.

Authors:  B L Robbins; J Greenhaw; M C Connelly; A Fridland
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

View more
  1 in total

1.  Synthesis, structure and biological activity of a new and efficient Cd(II)-uracil derivative complex system for cleavage of DNA.

Authors:  Nuria A Illán-Cabeza; Rosario A Vilaplana; Ysmael Alvarez; Khalid Akdi; Sanae Kamah; Francisco Hueso-Ureña; Miguel Quirós; Francisco González-Vílchez; Miguel N Moreno-Carretero
Journal:  J Biol Inorg Chem       Date:  2005-11-03       Impact factor: 3.358

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.